Molecular Loop Biosciences, Inc.
LoopCap™ technology, a chemistry-based targeted sequencing platform combining target capture and library preparation
- Sector
- Biotech
- Headquarters
- Newton, MA
- Founded
- 2018
- Latest Form D
- $1.8M, Jan 2022
- Total capital
- $4.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.3M
- 2 Form D · last Jan 2022
- 57 months since last filing
- Federal contracts
- $1M
- 2 awards · Health and Human S
- Rank in Biotech#185 of 4373
- Granted patents
- 7
- 4 pending · first 2022
- Rank in peer group#33 of 342
Capital timeline
Latest events
- Federal contractHealth and Human S · Index Primer Kit-pacbio$239K
- Federal contractHealth and Human S · Gsl Reagents$794K
- Private capital raisedForm D · SEC · 2nd filing$1.8M
- Private capital raisedForm D · SEC · 1st filing$1.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#33 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Gregory PorrecaResearcherExecutive Officer, DirectorLinked by 2 patents
- Christopher McGuinessDirectorNamed in SEC Form D filings
- Christopher McGuinnessDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 11- PendingScreening For Structural VariantsUSPTOApplication 18336198
- GrantedCapture ReactionsUSPTOUS 12,110,537
- PendingMethods And Compositions For Evaluating Genetic MarkersUSPTOApplication 18483878
Show all 11 patent records
- Screening For Structural VariantsDec 19, 2024 · Application 18336198Pending
- Capture ReactionsOct 8, 2024 · US 12,110,537Granted
- Methods And Compositions For Evaluating Genetic MarkersOct 3, 2024 · Application 18483878Pending
- Methods For Determining Carrier StatusSep 3, 2024 · US 12,077,822Granted
- Methods For Maintaining The Integrity And Identification Of A Nucleic Acid Template In A Multiplex Sequencing ReactionFeb 8, 2024 · Application 18447987Pending
- Methods And Compositions For Evaluating Genetic MarkersDec 12, 2023 · US 11,840,730Granted
- Methods For Maintaining The Integrity And Identification Of A Nucleic Acid Template In A Multiplex Sequencing ReactionSep 26, 2023 · US 11,768,200Granted
- Screening For Structural VariantsJun 20, 2023 · US 11,680,284Granted
- Methods For Selectively Suppressing Non-target SequencesOct 20, 2022 · Application 17856072Pending
- Methods For Selectively Suppressing Non-target SequencesAug 9, 2022 · US 11,408,024Granted
- Methods For Copy Number DeterminationMay 24, 2022 · US 11,339,435Granted
Related companies, and why
- ANTIRADICAL THERAPEUTICS LLCSimilar federal contract value in Biotech · $1.1M in contracts
- Zen-Bio, Inc.Similar federal contract value in Biotech · $1.1M in contracts
- SunFire Biotechnologies LLCSimilar federal contract value in Biotech · $1.1M in contracts
- OXFORD BIOMEDICAL RESEARCH, INC.Similar federal contract value in Biotech · $1M in contracts
- Gliknik IncSimilar federal contract value in Biotech · $1M in contracts
- Flow Pharma, Inc.Similar federal contract value in Biotech · $1.0M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .